Characterizing the Roles of BRAF, PTEN and Cdkn2a in Novel Mouse Models of Melanoma Formation and Progression

There will be an estimated 60,000 new cases and nearly 8000 deaths in the US this year due to malignant melanoma. People living in the US are expected to have a 1 in 71 lifetime risk of developing the disease. Activating mutations in BRAF occur in approximately 60% of melanomas and in 80% of beni...

Full description

Bibliographic Details
Main Author: Curley, David
Format: Others
Published: ScholarWorks @ UVM 2008
Subjects:
Online Access:http://scholarworks.uvm.edu/graddis/62
http://scholarworks.uvm.edu/cgi/viewcontent.cgi?article=1061&context=graddis